Case Report
BibTex RIS Cite

Safra kesesi kanserine bağlı gelişen hemobilinin başarılı tedavisi

Year 2020, Volume: 2 Issue: 3, 91 - 93, 28.06.2020
https://doi.org/10.38053/acmj.644617

Abstract

Hemobili, hepatobiliyer trakttan kaynaklı kanama olup üst gastrointestinal
kanamanın nadir bir sebebidir. Hemobilinin en yaygın nedenleri iyatrojenik,
travmatojenik ve neoplastik nedenlerdir. Tedavide ise endoskopik olarak kanama
kontrolü ve kanayan damarın anjiyografik olarak embolizasyonu kombine olarak
kullanılmaktadır. Biz bu vakada 71 yaşında inoperable safra kesesi kanseri
tanısı olup hemobili ve bilier obstuksiyon semptomları ile başvuran bir
hastanın tedavisinden bahsedeceğiz.

References

  • Green M, Duell R, Johnson C, Jamieson N. Haemobilia. Br J Surg. 2001; 88: 773-86.
  • Cathcart S, Birk JW, Tadros M, Schuster M. Hemobilia: An Uncommon But Notable Cause of Upper Gastrointestinal Bleeding. J Clin Gastroenterol. 2017; 51: 796-804.
  • Berry R, Han JY, Kardashian AA, LaRusso NF, Tabibian JH. Hemobilia: Etiology, diagnosis, and treatment. Liver Res. 2018; 2: 200-8.
  • Zhornitskiy A, Berry R, Han JY, Tabibian JH. Hemobilia: Historical overview, clinical update, and current practices. Liver Int. 2019; 39: 1378-88.
  • Bektas M. Hemobilia and Hemosuccus Pancreaticus. Turkiye Klinikleri J Gastroenterohepatol-Special Topics. 2008; 1: 32-4
  • Khamaysi I, Suissa A. Hemobilia. Gastrointest Endosc. 2017; 86: 1176-7.
  • Bismuth H. Hemobilia. N Engl J Med 1973; 288: 617-9
  • Sadamori H, Fujiwara H, Tanaka T,ve ark. Carcinosarcoma of the gallbladder manifesting as cholangitis due to hemobilia. J Gastrointest Surg. 2012; 16: 1278
  • Páez Cumpa C, Erimeiku Barahona A, Payeras Capó MA, Amengual Antich I, Garrido Durán C. Hemobilia due to intracholecystic papillary neoplasm. Rev Esp Enferm Dig. 2017; 109: 70-3.

Safra kesesi kanserine bağlı gelişen hemobilinin başarılı tedavisi

Year 2020, Volume: 2 Issue: 3, 91 - 93, 28.06.2020
https://doi.org/10.38053/acmj.644617

Abstract

Hemobilia is bleeding from the hepatobiliary tract and a rare cause of
acute upper gastrointestinal bleeding.
The most common causes of hemobilia are iatrogenic, traumatogenic, and
neoplastic. In the treatment, endoscopic bleeding control and angiographic
embolization of the bleeding vessel are used in combination. In this case
report, we present a 71-year-old patient with inoperable gallbladder cancer who
presented with hemobilia and biliary obstruction symptoms.

References

  • Green M, Duell R, Johnson C, Jamieson N. Haemobilia. Br J Surg. 2001; 88: 773-86.
  • Cathcart S, Birk JW, Tadros M, Schuster M. Hemobilia: An Uncommon But Notable Cause of Upper Gastrointestinal Bleeding. J Clin Gastroenterol. 2017; 51: 796-804.
  • Berry R, Han JY, Kardashian AA, LaRusso NF, Tabibian JH. Hemobilia: Etiology, diagnosis, and treatment. Liver Res. 2018; 2: 200-8.
  • Zhornitskiy A, Berry R, Han JY, Tabibian JH. Hemobilia: Historical overview, clinical update, and current practices. Liver Int. 2019; 39: 1378-88.
  • Bektas M. Hemobilia and Hemosuccus Pancreaticus. Turkiye Klinikleri J Gastroenterohepatol-Special Topics. 2008; 1: 32-4
  • Khamaysi I, Suissa A. Hemobilia. Gastrointest Endosc. 2017; 86: 1176-7.
  • Bismuth H. Hemobilia. N Engl J Med 1973; 288: 617-9
  • Sadamori H, Fujiwara H, Tanaka T,ve ark. Carcinosarcoma of the gallbladder manifesting as cholangitis due to hemobilia. J Gastrointest Surg. 2012; 16: 1278
  • Páez Cumpa C, Erimeiku Barahona A, Payeras Capó MA, Amengual Antich I, Garrido Durán C. Hemobilia due to intracholecystic papillary neoplasm. Rev Esp Enferm Dig. 2017; 109: 70-3.
There are 9 citations in total.

Details

Primary Language Turkish
Subjects Health Care Administration
Journal Section Case Report
Authors

Mustafa Kaplan 0000-0002-6959-675X

Mustafa Özdemir 0000-0001-9513-6768

Bülent Ödemiş This is me 0000-0001-6763-791X

Publication Date June 28, 2020
Published in Issue Year 2020 Volume: 2 Issue: 3

Cite

APA Kaplan, M., Özdemir, M., & Ödemiş, B. (2020). Safra kesesi kanserine bağlı gelişen hemobilinin başarılı tedavisi. Anadolu Güncel Tıp Dergisi, 2(3), 91-93. https://doi.org/10.38053/acmj.644617
AMA Kaplan M, Özdemir M, Ödemiş B. Safra kesesi kanserine bağlı gelişen hemobilinin başarılı tedavisi. Anatolian Curr Med J. June 2020;2(3):91-93. doi:10.38053/acmj.644617
Chicago Kaplan, Mustafa, Mustafa Özdemir, and Bülent Ödemiş. “Safra Kesesi Kanserine bağlı gelişen Hemobilinin başarılı Tedavisi”. Anadolu Güncel Tıp Dergisi 2, no. 3 (June 2020): 91-93. https://doi.org/10.38053/acmj.644617.
EndNote Kaplan M, Özdemir M, Ödemiş B (June 1, 2020) Safra kesesi kanserine bağlı gelişen hemobilinin başarılı tedavisi. Anadolu Güncel Tıp Dergisi 2 3 91–93.
IEEE M. Kaplan, M. Özdemir, and B. Ödemiş, “Safra kesesi kanserine bağlı gelişen hemobilinin başarılı tedavisi”, Anatolian Curr Med J, vol. 2, no. 3, pp. 91–93, 2020, doi: 10.38053/acmj.644617.
ISNAD Kaplan, Mustafa et al. “Safra Kesesi Kanserine bağlı gelişen Hemobilinin başarılı Tedavisi”. Anadolu Güncel Tıp Dergisi 2/3 (June 2020), 91-93. https://doi.org/10.38053/acmj.644617.
JAMA Kaplan M, Özdemir M, Ödemiş B. Safra kesesi kanserine bağlı gelişen hemobilinin başarılı tedavisi. Anatolian Curr Med J. 2020;2:91–93.
MLA Kaplan, Mustafa et al. “Safra Kesesi Kanserine bağlı gelişen Hemobilinin başarılı Tedavisi”. Anadolu Güncel Tıp Dergisi, vol. 2, no. 3, 2020, pp. 91-93, doi:10.38053/acmj.644617.
Vancouver Kaplan M, Özdemir M, Ödemiş B. Safra kesesi kanserine bağlı gelişen hemobilinin başarılı tedavisi. Anatolian Curr Med J. 2020;2(3):91-3.

Interuniversity Board (UAK) Equivalency: 1b [Original research article published in journals scanned by international field indexes (included in indices other than the ones mentioned in 1a) - 10 POINTS].


The Directories (indexes) and Platforms we are included in are at the bottom of the page.


DRJI_Logo.png

images?q=tbn%3AANd9GcRWim7w8Nom2D_r9TU9zUwWMOHMJ8iKKIpguhpKWgjUk7boKUd7r7Q9vnfb&usqp=CAU&ec=45668930

asos-index.png

images?q=tbn%3AANd9GcTN0XfC7LTwLrnzxtwDZ4r2blTmXJAUSeC3lcQDSNsXdN2K_p3_

  worldcat.gif

general.png          logo-large-explore.png


1*mvsP194Golg0Dmo2rjJ-oQ.jpeg

     

images?q=tbn%3AANd9GcQpdiyYauDxE8R_l6TzyujZwADZDe53xx9gDg&usqp=CAU


Journal is indexed in;


Crossref (DOI), Google Scholar, EuroPub, Directory of Research Journal İndexing (DRJI), Worldcat (OCLC), General Impact Factor, OpenAIRE, ASOS Index, ROAD, Turkiye Citation Index, Turk Medline


Ulakbim-TR DizinIndex Copernicus, EBSCO, DOAJ is under evaluation.


Journal articles are evaluated as "Double-Blind Peer Review"

.

There is no charge for sending articles, submitting, evaluating and publishing.


Assoc Prof Dr  Muhammed KIZILGÜL was qualified as an Associated Editor in ACMJ on 15/02/2020,

Assoc. Prof. Dr. Ercan YUVANÇ leaved, Assoc. Prof. Dr. Alpaslan TANOĞLU became the Editör in Chief in ACMJ on 13/05/2020.